After a little research it appears that shorts are working overtime to hold Catalyst Pharmaceuticals (Nasdaq: CPRX) under $3.0. Only 5 days ago we were at $3.20. A month ago and before the PDUFA date … [Read more...] about Shorts Fighting To Keep CPRX from Gaining Momentum-Insiders Aren’t Phased
MS Picks November 2018
CPRX Swing Move For November 2018
Investment Overview MSMM believes Catalyst Pharmaceuticals (Nasdaq: CPRX $2.88) is a good swing-move for the remainder of November of 2018. The company has a PDUFA action date on November 28th … [Read more...] about CPRX Swing Move For November 2018
Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath
Overview Wednesday October 24th, 2018 the stock market was slashed across the board with the DOW erasing all its gains for the year and dripping red. The Nasdaq was hit with equal force. Comments from … [Read more...] about Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath
Stereotaxis Is A Reduced Risk Play in The Cardiac Robotics Market
Introduction There is no doubt that robotics do and will continue to play an increasingly crucial role in healthcare. Chances are if you go in for routine surgery tomorrow your doctor will be assisted … [Read more...] about Stereotaxis Is A Reduced Risk Play in The Cardiac Robotics Market
You must be logged in to post a comment.